Accessibility Menu
Curaleaf Stock Quote

Curaleaf (TSX: CURA)

$3.04
(0.0%)
+0.00
Price as of November 25, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
CA$3.04
Daily Change
(0.0%) +$0.00
Day's Range
CA$2.91 - CA$3.10
Previous Close
CA$3.04
Open
CA$3.04
Beta
1.29
Volume
249,172
Average Volume
1,008,067
Market Cap
2.3B
Market Cap / Employee
$3.04M
52wk Range
CA$0.99 - CA$5.00
Revenue
-
Gross Margin
0.36%
Dividend Yield
N/A
EPS
-CA$0.49
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Curaleaf Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
CURA+11.36%-78.5%-26.47%-65%
S&P+13%+86.41%+13.26%+152%

Curaleaf Company Info

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$441.08M-2.2%
Gross Profit$171.48M3.4%
Gross Margin38.88%2.1%
Market Cap$2.93B-4.3%
Net Income-$75.13M-24.2%
EBITDA$80.44M-11.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$149.56M23.1%
Accounts Receivable$93.98M11.3%
Inventory318.83.9%

Liabilities

Q3 2025YOY Change
Long Term Debt$1.33B5.9%
Short Term Debt$113.02M-35.8%

Ratios

Q3 2025YOY Change
Return On Assets-8.39%-2.2%
Return On Invested Capital-9.23%-0.1%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$44.64M124.4%
Operating Free Cash Flow$67.45M16.7%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book1.290.810.742.469.39%
Price to Sales0.910.540.491.64-0.90%
Price to Tangible Book Value-1.54-0.81-0.68-2.60-8.94%
Price to Free Cash Flow TTM17.6411.2612.6131.22-49.56%
Enterprise Value to EBITDA33.2728.9527.8953.708.02%
Free Cash Flow Yield5.7%8.9%7.9%3.2%98.26%
Return on Equity-23.4%-25.1%-25.5%-28.2%48.13%
Total Debt$1.53B$1.53B$1.44B$1.44B0.76%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.